Mark D. Smith - 17 May 2022 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
Director
Signature
/s/ Adam C. Vandervoort, Attorney-in-Fact
Issuer symbol
TDOC
Transactions as of
17 May 2022
Transactions value $
$0
Form type
4
Filing time
18 May 2022, 16:20:45 UTC
Previous filing
06 Dec 2021
Next filing
31 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise +819 +23.16% 4.36K 17 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Restricted Stock Units Options Exercise $0 -819 -50% $0.00 819 17 May 2022 Common Stock 819 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2 Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F3 On May 17, 2021, the reporting person was granted 1,638 restricted stock units, vesting in full on May 17, 2022. 50% of the vested shares will be delivered to the reporting person on the earliest to occur of (i) within 90 days following the date that is 30 days following the reporting person's separation of service, (ii) immediately prior to, on or within 30 days following a Change of Control (as defined in the issuer's Deferred Compensation Plan for Non-Employee Directors) and (iii) the reporting person's death.